NT COVID-19 update31 January 2022
There were 760 new cases of COVID-19 recorded in the Northern Territory (NT) in the 24 hours to 8pm on 30 January 2022. Of these, 599 were positive cases from a Rapid Antigen Test (RAT).
Following the submission of further RAT results, we have also amended the case number for the 24 hour reporting period to 8pm on 29 January to 901.
There were 528 cases recorded in the Top End region, 86 in Central Australia, 45 in the East Arnhem region, 16 in the Big Rivers region and 13 in the Barkly region.
New cases recorded in communities under lock-in restrictions:
- 27 cases in Galiwin’ku
- 3 cases in Milingimbi
- 1 case in Palumpa.
There are currently 114 patients in hospital, with nine patients requiring oxygen. There are 5 patients in ICU.
The number of active cases in the NT is about 5,550.
902 COVID-19 PCR tests were processed across the NT yesterday.
Public health measures
To slow the spread of COVID-19 in our community and reduce the rate of transmission the following public health measures are in place across the NT:
- a lock-in for Ampilatwatja, Milikapiti, Galiwin’ku, Milingimbi, Palumpa until 2pm on Sunday 6 February
- a Territory-wide mask mandate (indoors and outdoors)
- the Territory Vaccine Pass.
Everyone should get tested for COVID-19 if showing symptoms. A number of NT Rapid Antigen Testing and Distribution Points have been established.
Individuals can collect RATs for free from NT distribution centres located in Darwin, Katherine, Nhulunbuy, Alice Springs and Tennant Creek.
To reduce the risk of COVID-19 spreading in our communities, it is important for everyone to follow all the health directions:
- Book your COVID-19 vaccine
- Check in using The Territory Check In App every time, everywhere
- If you have symptoms, stay away from others and get tested for COVID-19
- Wash your hands with soap and water and use hand sanitiser regularly
- Do not go to work if you feel sick
- Maintain a physical distance of 1.5 metres where possible.
View information on COVID-19 symptoms and testing.